现已上线！2025 年 Telegram 研究 — 年度关键洞察 
Chart Commando
前往频道在 Telegram
Disclaimer: All information & Charts are given only for educational purpose.You can paper trade only.I am not a SEBI Registered analyst. For queries- https://bit.ly/3PKOCZ3 Registration Details bit.ly/4uM3iK1
显示更多📈 Telegram 频道 Chart Commando 的分析概览
频道 Chart Commando (@chartcommando) 英语 语言赛道中的 是活跃参与者。目前社区聚集了 28 409 名订阅者，在 经济与金融 类别中位列第 4 277，并在 印度 地区排名第 14 709 位。
📊 受众指标与增长动态
自 невідомо 创建以来，项目保持高速增长，吸引了 28 409 名订阅者。
根据 26 六月, 2026 的最新数据，频道保持稳定运转。过去 30 天订阅人数变化为 -455，过去 24 小时变化为 -8，整体触达仍然可观。
- 认证状态： 未认证
- 互动率 (ER)： 平均受众互动率为 8.75%。内容发布后 24 小时内通常能获得 4.76% 的反应，占订阅者总量。
- 帖子覆盖： 每篇帖子平均可获得 2 487 次浏览，首日通常累积 1 354 次浏览。
- 互动与反馈： 受众积极参与，单帖平均反应数为 12。
- 主题关注点： 内容集中在 nifty, weak, resistance, near, markets 等核心主题上。
📝 描述与内容策略
作者将该频道定位为表达主观观点的平台：
“Disclaimer:
All information & Charts are given only for educational purpose.You can paper trade only.I am not a SEBI Registered analyst.
For queries-
https://bit.ly/3PKOCZ3
Registration Details
bit.ly/4uM3iK1”
凭借高频更新（最新数据采集于 27 六月, 2026），频道始终保持新鲜度与高覆盖。分析显示受众积极互动，使其成为 经济与金融 类别中的关键影响点。
28 409
订阅者
-824 小时
-1057 天
-45530 天
帖子存档
28 398
Repost from Chart Commando
💢𝐅𝐎𝐑 𝐕𝐈𝐏 𝐂𝐇𝐀𝐍𝐍𝐄𝐋 𝐎𝐏𝐄𝐍 𝐃𝐄𝐌𝐀𝐓𝐄 𝐀𝐂𝐂𝐎𝐔𝐍𝐓 𝐅𝐎𝐑𝐌 𝐎𝐔𝐑 𝐋𝐈𝐍𝐊 👇
🔗Link :- Click here
💢Download Chart Commando Learning App get 2 free course 👇
🔗Link :- Click here
💥For Beginners💥
1.Stock Market Trading (SMT)
2.Earn Unlimited in Downtrend
🏆Advance learnings program🏆
1. 3rd Wave Trader ( Stress free Wealth Creation )
2. Option Buying Strategies ( ABOM )
3. Option Selling Strategies ( ABOM )
4. Option Buying + Option Selling (Combo ABOM )
5. Best Price Action Pattern (BAP)
6. Stock Market Trading (SMT) + Best Price Action Pattern (BAP) (Combo) 👇
🔗Link :- Click here
28 398
Dear Commandos, Plan Your Trading👇
For your today's earning In Stock watch it again & again & plan your trade 👍
This sessions can gives big profits to you
https://youtube.com/live/NU6xyZq7ur8?feature=share
28 398
💥Zydus Lifesciences: Zydus Announces Exclusive Licensing and Supply Agreement for Two Gadolinium Based Magnetic Resonance Imaging (MRI) Injectable, Contrast Agents in the US Total Addressable Market Opportunity for Gadobutrol Injection is Estimated at US$ 120M, and for Gadoterate Meglumine Injection at US$ 117M in the US Market (As Per IQVIA MAT Jul - 2024)
💥Laurus Labs: Co Says USFDA Audit Completed Today for Our API Manufacturing Facility at Hyderabad (DS-1, IKP Knowledge Park, Genome Valley, Shameerpet, Telangana) Without Any 483 Observation
💥GMR Airports: Co Says Total Passenger Traffic for August Up 9% (YoY) August Domestic Traffic Up 7.4% (YoY); August International Traffic Up 12.9% (YoY)
💥Seshasayee Paper and Boards: Co Approved Erode Project Undertaking for 4.05B Rupees Project Approval Subject to Environment Ministry Nod
💥Allcargo Terminals: Co to Enter Into the Lease Agreement for Land Parcel Admeasuring Approximately 25 Acres at Village Khopta, Uran Raigad, Maharashtra, for Business/Capacity Expansion
💥G R Infraprojects: Co Entered Into Agreement With Bharat Highways InvIT Agreement for Transfer of 100% Shares of Co's Unit; Agreement for 986.1M Rupees
💥Zomato: Co Teams Up With IRCTC to Offer Food Delivery Service on Trains - Business Standard
28 398
💢Very quiet start to Asia-Pac trade amid the holiday-thinned conditions with many key markets on an extended weekend and as participants brace for this week's central bank meetings including the FOMC: ASX 200 (+0.2%), Nikkei 225 (Closed), KOSPI (Closed).
💢Stocks Ban in F&O: Artiind, Balramchini, Bandhanbnk, Chambalfert, Granules, Hindcopper, Rblbank
💢Stocks to Watch: Zydus Lifesciences, Laurus Labs, GMR Airports, Seshasayee Paper and Boards, Allcargo Terminals, G R Infraprojects, Zomato
